Differential interleukin-6 (IL-6) responses of three established myeloma cell lines in the presence of soluble human IL-6 receptors

Leukemia Research

Volumn 20, Issue 4, 1996, Pages 291-301

  Diamant, Marcus ^a   Hansen, Morten B ^a   Rieneck, Klaus ^a   Svenson, Morten ^a   Yasukawa, Kiyoshi ^b   Bendtzen, Klaus ^a  

^a Rigshospitalet   (Denmark)

^b TOSOH CORPORATION   (Japan)

Author keywords

gp130; Interleukin 6; Multiple myeloma; Proliferation; Soluble IL 6 receptors

Indexed keywords

INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; IODINE 125; MESSENGER RNA; THYMIDINE; TRITIUM;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MYELOMA CELL; NORTHERN BLOTTING; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0029950150     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/0145-2126(95)00077-1     Document Type: Article

References (54)

1. Taga T., Hibi M., Hirata Y., Yamasaki K., Yasukawa K., Matsuda T., Hirano T. & Kishimoto T. (1989) Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130. Cell 58, 573.
2. Hibi M., Murakami M., Saito M., Hirano T., Taga T. & Kishimoto T. (1990) Molecular cloning and expression of an IL-6 signal transducer, gp130. Cell 63, 1149.
3. Gearing D.P., Comeau M.R., Friend D.J., Gimpel S.D., Thut C.J., McGourty J., Brasher K.K., King J.A., Gillis S., Mosley B., et al. (1992) The IL-6 signal transducer, gp130: an oncostatin M receptor and affinity converter for the LIF receptor. Science 255, 1434.
4. Taga T., Narazaki M., Yasukawa K., Saito T., Miki D., Hamaguchi M., Davis S., Shoyab M., Yancopoulos G.D. & Kishimoto T. (1992) Functional inhibition of hematopoietic and neurotrophic cytokines by blocking the interleukin 6 signal transducer gp130. Proc. Natl. Acad. Sci. U.S.A. 89, 10998.
5. Liu J., Modrell B., Aruffo A., Marken J.S., Taga T., Yasukawa K., Murakami M., Kishimoto T. & Shoyab M. (1992) Interleukin-6 signal transducer gp130 mediates oncostatin M signaling. J. Biol. Chem. 267, 16763.
6. Ip N.Y., Nye S.H., Boulton T.G., Davis S., Taga T., Li Y., Birren S.J., Yasukawa K., Kishimoto T., Anderson D.J., et al. (1992) CNTF and LIF act on neuronal cells via shared signaling pathways that involve the IL-6 signal transducing receptor component gp130. Cell 69, 1121.
7. Yin T., Taga T., Tsang M.L., Yasukawa K., Kishimoto T. & Yang Y.C. (1993) Involvement of IL-6 signal transducer gp130 in IL-11-mediated signal transduction. J. Immunol. 151, 2555.
8. Honda M., Yamamoto S., Cheng M., Yasukawa K., Suzuki H., Saito T., Osugi Y., Tokunaga T. & Kishimoto T. (1992) Human soluble IL-6 receptor: its detection and enhanced release by HIV infection. J. Immunol. 148, 2175.
9. Novick D., Engelmann H., Wallach D. & Rubinstein M. (1989) Soluble cytokine receptors are present in normal human urine. J. Exp. Med. 170, 1409.
10. Nakajima T., Yamamoto S., Cheng M., Yasukawa K., Hirano T., Kishimoto T., Tokunaga T. & Honda M. (1992) Soluble interleukin-6 receptor is released from receptor-bearing cell lines in vitro. Jpn. J. Cancer Res. 83, 373.
11. Mullberg J., Schooltink H., Stoyan T., Gunther M., Graeve L., Buse G., Mackiewicz A., Heinrich P.C. & Rose John S. (1993) The soluble interleukin-6 receptor is generated by shedding. Eur. J. Immunol. 23, 473.
12. Lust J.A., Donovan K.A., Kline M.P., Greipp P.R., Kyle R.A. & Maihle N.J. (1992) Isolation of an mRNA encoding a soluble form of the human interleukin-6 receptor. Cytokine 4, 96.
13. Novick D., Engelmann H., Revel M., Leitner O. & Rubinstein M. (1991) Monoclonal antibodies to the soluble human IL-6 receptor: affinity purification, ELISA, and inhibition of ligand binding. Hybridoma 10, 137.
14. Yasukawa K., Futatsugi K., Saito T., Yawata H., Narazaki M., Suzuki H., Taga T. & Kishimoto T. (1992) Association of recombinant soluble IL-6-signal transducer, gp130, with a complex of IL-6 and soluble IL-6 receptor, and establishment of an ELISA for soluble gp130. Immunol. Lett. 31, 123.
15. Gaillard J.P., Bataille R., Brailly H., Zuber C., Yasukawa K., Attal M., Maruo N., Taga T., Kishimoto T. & Klein B. (1993) Increased and highly stable levels of functional soluble interleukin-6 receptor in sera of patients with monoclonal gammopathy. Eur. J. Immunol. 23, 820.
16. Novick D., Shulman L.M., Chen L. & Revel M. (1992) Enhancement of interleukin 6 cytostatic effect on human breast carcinoma cells by soluble IL-6 receptor from urine and reversion by monoclonal antibody. Cytokine 4, 6.
17. Narazaki M., Yasukawa K., Saito T., Ohsugi Y., Fukui H., Koishihara Y., Yancopoulos G.D., Taga T. & Kishimoto T. (1993) Soluble forms of the interleukin-6 signal-transducing receptor component gp130 in human serum possessing a potential to inhibit signals through membrane-anchored gp130. Blood 82, 1120.
18. Aderka D., Maor Y., Novick D., Engelmann H., Kahn Y., Levo Y., Wallach D. & Revel M. (1993) Interleukin-6 inhibits the proliferation of B-chronic lymphocytic leukemia cells that is induced by tumor necrosis factor-alpha or -beta. Blood 81, 2076.
19. Suzuki H., Yasukawa K., Saito T., Narazaki M., Hasegawa A., Taga T. & Kishimoto T. (1993) Serum soluble interleukin-6 receptor in MRL/lpr mice is elevated with age and mediates the interleukin-6 signal. Eur. J. Immunol. 23, 1078.
20. Mackiewicz A., Schooltink H., Heinrich P.C. & Rose John S. (1992) Complex of soluble human IL-6-receptor/IL-6 up-regulates expression of acute-phase proteins. J. Immunol. 149, 2021.
21. Diamant M., Hansen M.B., Rieneck K., Svenson M., Yasukawa K. & Bendtzen K. (1994) Stimulation of the B9 hybridoma cell line by soluble interleukin-6 receptors. J. Immunol. Methods 173, 229.
22. Nilsson K., Jernberg H. & Pettersson M. (1990) IL-6 as a growth factor for human multiple myeloma cells - a short overview. Curr. Top. Microbiol. Immunol. 166, 3.
23. Hirano T. (1991) Interleukin 6 (IL-6) and its receptor: their role in plasma cell neoplasias. Int. J. Cell Cloning. 9, 166.
24. Kawano M., Hirano T., Matsuda T., Taga T., Horii Y., Iwato K., Asaoku H., Tang B., Tanabe O., Tanaka H., et al. (1988) Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas. Nature 332, 83.
25. Klein B., Zhang X.G., Jourdan M., Portier M. & Bataille R. (1990) Interleukin-6 is a major myeloma cell growth factor in vitro and in vivo especially in patients with terminal disease. Curr. Top. Microbiol. Immunol 166, 23.
26. Klein B., Zhang X.G., Jourdan M., Boiron J.M., Portier M., Lu Z.Y., Wijdenes J., Brochier J. & Bataille R. (1990) Interleukin-6 is the central tumor growth factor in vitro and in vivo in multiple myeloma. Eur. Cytokine. Netw. 1, 193.
27. Zhang X.G., Bataille R., Widjenes J. & Klein B. (1992) Interleukin-6 dependence of advanced malignant plasma cell dyscrasias. Cancer 69, 1373.
28. Anderson K.C., Jones R.M., Morimoto C., Leavitt P. & Barut B.A. (1989) Response patterns of purified myeloma cells to hematopoietic growth factors. Blood 73, 1915.
29. Klein B., Wijdenes J., Zhang X.G., Jourdan M., Boiron J.M., Brochier J., Liautard J., Merlin M., Clement C., Morel Fournier B., et al. (1991) Murine anti-interleukin-6 monoclonal antibody therapy for a patient with plasma cell leukemia. Blood 78, 1198.
30. Jernberg H., Pettersson M., Kishimoto T. & Nilsson K. (1991) Heterogeneity in response to interleukin 6 (IL-6), expression of IL-6 and IL-6 receptor mRNA in a panel of established human multiple myeloma cell lines. Leukemia 5, 255.
31. Barut B.A., Zon L.I., Cochran M.K., Paul S.R., Chauhan D., Mohrbacher A., Fingeroth J. & Anderson K.C. (1992) Role of interleukin 6 in the growth of myeloma-derived cell lines. Leukemia Res. 16, 951.
32. Jernberg Wiklund H., Pettersson M., Carlsson M. & Nilsson K. (1992) Increase in interleukin 6 (IL-6) and IL-6 receptor expression in a human multiple myeloma cell line, U-266, during long-term in vitro culture and the development of a possible autocrine IL-6 loop. Leukemia 6, 310.
33. Schwab G., Siegall C.B., Aarden L.A., Neckers L.M. & Nordan R.P. (1991) Characterization of an interleukin-6-mediated autocrine growth loop in the human multiple myeloma cell line, U266. Blood 77, 587.
34. Levy Y., Tsapis A. & Brouet J.C. (1991) Interleukin-6 antisense oligonucleotides inhibit the growth of human myeioma cell lines. J. Clin. Invest. 88, 696.
35. Hata H., Matsuzaki H. & Takatsuki K. (1990) Autocrine growth by two cytokines, interleukin-6 and tumor necrosis factor alpha, in the myeloma cell line KHM-1A. Acta Haematol. 83, 133.
36. Asaoku H., Kawano M., Iwato K., Tanabe O., Tanaka H., Hirano T., Kishimoto T. & Kuramoto A. (1988) Decrease in BSF-2/IL-6 response in advanced cases of multiple myeloma. Blood 72, 429.
37. Zhang X.G., Klein B. & Bataille R. (1989) Interleukin-6 is a potent myeloma-cell growth factor in patients with aggressive multiple myeloma. Blood 74, 11.
38. Nilsson K., Bennich H., Johansson S.G. & Ponten J. (1970) Established immunoglobulin producing myeloma (IgE) and lymphoblastoid (IgG) cell lines from an IgE myeloma patient. Clin. Exp. Immunol. 7, 477.
39. Diehl V., Schaadt M., Kirchner H., Hellriegel K.P., Gudat F., Fonatsch C., Laskewitz E. & Guggenheim R. (1978) Long-term cultivation of plasma cell leukemia cells and autologous lymphoblasts (LCL) in vitro: a comparative study. Blut 36, 331.
40. Miller C.H., Carbonell A., Peng R., Paglieroni T. & Mackenzie M.R. (1982) A human plasma cell line: induction and characterization. Cancer 49, 2091.
41. Lansdorp P.M., Aarden L.A., Calafat J. & Zeiljemaker W.P. (1986) A growth-factor dependent B-cell hybridoma. Curr. Top. Microbiol. Immunol. 132, 105.
42. Kishimoto T. & Hirano T. (1988) Molecular regulation of B lymphocyte response. Annu. Rev. Immunol. 6, 485.
43. Yasukawa K., Saito T., Fukunaga T., Sekimori Y., Koishihara Y., Fukui H., Ohsugi Y., Matsuda T., Yawata H., Hirano T., et al. (1990) Purification and characterization of soluble human IL-6 receptor expressed in CHO cells. J. Biochem. Tokyo. 108, 673.
44. Hansen M.B., Svenson M., Diamant M. & Bendtzen K. (1993) High-affinity IgG autoantibodies to IL-6 in sera of normal individuals are competitive inhibitors of IL-6 in vitro. Cytokine 5, 72.
45. Hirano T., Yasukawa K., Harada H., Taga T., Watanabe Y., Matsuda T., Kashiwamura S., Nakajima K., Koyama K., Iwamatsu A., et al. (1986) Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature 324, 73.
46. Yamasaki K., Taga T., Hirata Y., Yawata H., Kawanishi Y., Seed B., Taniguchi T., Hirano T. & Kishimoto T. (1988) Cloning and expression of the human interleukin-6 (BSF-2/IFN beta 2) receptor. Science 241, 825.
47. Fort P., Marty L., Piechaczyk M., el Sabrouty S., Dani C., Jeanteur P. & Blanchard J.M. (1985) Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family. Nucleic. Acids. Res. 13, 1431.
48. Chomczynski P. & Sacchi N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156.
49. Sambrook J., Fritsch E. F. & Maniatis T. (1989) Molecular Cloning: A Laboratory Manual. Cold Spring Harbor University Press, Cold Spring Harbor, N.Y.
50. Roth J. (1975) Methods for assesing immunologic and biologic properties of iodinated peptide hormones. In Methods of Enzymology 37. Hormone Action Part B. Peptide Hormones, pp. 223-233.
51. Hirata Y., Taga T., Hibi M., Nakano N., Hirano T. & Kishimoto T. (1989) Characterization of IL-6 receptor expression by monoclonal and polyclonal antibodies. J. Immunol. 143, 2900.
52. Saito T., Taga T., Miki D., Futatsugi K., Yawata H., Kishimoto T. & Yasukawa K. (1993) Preparation of monoclonal antibodies against the IL-6 signal transducer, gp130, that can inhibit IL-6-mediated functions. J. Immunol. Methods 163, 217.
53. Klein B., Zhang X.G., Jourdan M., Content J., Houssiau F., Aarden L., Piechaczyk M. & Bataille R. (1989) Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6. Blood 73, 517.
54. Schwabe M., Zhao J. & Kung H.F. (1994) Differential expression and ligand-induced modulation of the human interleukin-6 receptor on interleukin-6-responsive cells. J. Biol. Chem. 269, 7201.